Regeneron Says Its Antibody Cocktail Likely Weakened by Omicron Variant
TUESDAY, Nov. 30, 2021 (HealthDay News) — Regeneron Pharmaceuticals said Tuesday that its antibody cocktail, which is used widely to treat COVID-19 patients, may be less effective against the Omicron variant.The company noted that prior analyses sugg…
Learn MoreOmicron Variant Spurs New York Officials to Recommend Masking Indoors
TUESDAY, Nov. 30. 2021 (HealthDy News) — Amid growing concerns about the new Omicron variant, New York Governor Kathy Hochul and New York City Health Commissioner Dr. Dave Chokshi have advised all residents to wear masks while indoors.”Today, I am is…
Learn MorePfizer to Seek FDA Approval of Boosters for Teens Ages 16-17
TUESDAY, Nov. 30, 2021 (HealthDay News) — Pfizer Inc. is expected to seek approval this week for emergency use of its booster shots among American teens ages 16-17.Sources familiar with the matter told The New York Times that the U.S. Food and Drug A…
Learn MoreClinical Trials Are Becoming More Diverse, But There’s Still Work To Do
TUESDAY, Nov. 30, 2021 (HealthDay News) — U.S. cancer clinical trial participants have become more diverse in makeup, but certain groups remain underrepresented, a new study finds.It’s important to have a wide range of participants in clinical trials…
Learn MorePsychiatric Disorders and Type 2 Diabetes Often Go Together
TUESDAY, Nov. 30, 2021 (HealthDay News) — According to new research, people with psychiatric disorders often have to deal with another trouble: Higher rates of type 2 diabetes than the general population.”Increased prevalence of type 2 diabetes amon…
Learn MorePostpartum Depression Can Do Long-Term Harm to Women’s Finances
TUESDAY, Nov. 30, 2021 (HealthDay News) — Besides its terrible impact on mental health, postpartum depression can also bring long-term financial struggles to affected women, new research shows.”These findings highlight the importance of screening and…
Learn MoreMerck’s COVID-19 Pill Appears Effective, but May Pose Pregnancy Risks: FDA
MONDAY, Nov. 29, 2021 (HealthDay News) — Merck’s experimental COVID-19 antiviral pill appears effective, but may pose risks for pregnant women, including birth defects and toxicity to developing fetuses, according to the U.S. Food and Drug Administra…
Learn MoreBiden Pushes Vaccines, Masks as Best Defense Against Omicron Variant
MONDAY, Nov. 29, 2021 (HealthDay News) — Vaccines and masks will be the United States’ first line of defense against the new omicron variant, not lockdowns or border closures, President Joe Biden told the nation Monday.
“If people are vaccinated and …